Aster Capital Management »

Immunitybio shares owned by Aster Capital Management

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Aster Capital Management from 13F filings

Historical chart of Aster Capital Management investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Aster Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Aster Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $548k 182k 3.01
2025-12-31 $63 32 1.97

More positions owned by Aster Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Spdr Series Trust State Street Spd (KIE)
Spdr Series Trust State Street Spd (XHB)
Select Sector Spdr Tr State Street Uti (XLU)
Select Sector Spdr Tr State Street Hea (XLV)
Ishares Tr Expanded Tech (IGV)
First Tr Exchange-traded Dj Internt Idx (FDN)
Vaneck Etf Trust Oil Services Etf (OIH)
Coca-cola Europacific Partn E Shs (CCEP)
Wal-Mart Stores (WMT)
Blackrock (BLK)
Us Bancorp Com New (USB)
MPLX Com Unit Rep Ltd (MPLX)
Plains All Amern Pipeline L Unit Ltd Partn (PAA)
Select Sector Spdr Tr State Street Fin (XLF)

View all positions for Aster Capital Management

Top funds holding Immunitybio

Vanguard Group
BlackRock
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
D. E. Shaw & Co
Geode Capital Management
Susquehanna International
Citadel Advisors
Two Sigma Investments
LMR Partners
Morgan Stanley
Hrt Financial
Woodline Partners
Goldman Sachs Group

View all funds holding Immunitybio